fedratinib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for fedratinib, covering 2023-03-09 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) [Phase 2]